Literature DB >> 21979189

The association between anal function and neural degeneration after preoperative chemoradiotherapy followed by intersphincteric resection.

Yuji Nishizawa1, Satoshi Fujii, Norio Saito, Masaaki Ito, Atsushi Ochiai, Masanori Sugito, Akihiro Kobayashi, Yusuke Nishizawa.   

Abstract

BACKGROUND: Preoperative chemoradiotherapy for rectal cancer is administered to improve local control, but it can also induce severe anal dysfunction after surgery.
OBJECTIVE: The goals of the study were to assess the influence of preoperative chemoradiotherapy on pathological findings and to examine the correlation of these findings with the cause of severe anal dysfunction after intersphincteric resection.
DESIGN: Peripheral nerve degeneration was evaluated histopathologically with the use of hematoxylin and eosin-stained sections of surgical specimens after intersphincteric resection, based on karyopyknosis, vacuolar degeneration, acidophilic degeneration of cytoplasm, denucleation, and adventitial neuronal changes. Each item was scored to quantify the level of neural degeneration, and the relationship between degeneration and anal function was examined at 12 months after closure of the stoma. Anal function was assessed by questionnaire, and incontinence was evaluated based on the Wexner score.
SETTING: This study was conducted at the National Cancer Center Hospital East from 2001 to 2006. PATIENTS: The subjects were 68 patients with lower rectal cancer who underwent intersphincteric resection with (n = 47) or without (n = 21) preoperative chemoradiotherapy. MAIN OUTCOME MEASURES: The findings in the 2 groups were compared to clarify the association between the degree of histological degeneration and postoperative anal function.
RESULTS: Neural degeneration was significantly higher in the chemoradiotherapy group, and the neural degeneration and Wexner scores had a significant correlation (P = .003, r = 0.477).
CONCLUSION: Preoperative chemoradiotherapy induced marked neural degeneration around the rectal tumor. The significant correlation between the degeneration score and postoperative anal function suggests that this score may be a useful marker to predict the influence of preoperative chemoradiotherapy on anal function after surgery.

Entities:  

Mesh:

Year:  2011        PMID: 21979189     DOI: 10.1097/DCR.0b013e31822c94e6

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

Review 1.  [Late complications and functional disorders after rectal resection : Prevention, detection and therapy].

Authors:  J Reibetanz; M Kim; C-T Germer; N Schlegel
Journal:  Chirurg       Date:  2015-04       Impact factor: 0.955

2.  Differences in tissue degeneration between preoperative chemotherapy and preoperative chemoradiotherapy for colorectal cancer.

Authors:  Yuji Nishizawa; Satoshi Fujii; Norio Saito; Masaaki Ito; Kentaro Nakajima; Atsushi Ochiai; Masanori Sugito; Akihiro Kobayashi; Yusuke Nishizawa
Journal:  Int J Colorectal Dis       Date:  2012-02-29       Impact factor: 2.571

3.  Influence of neoadjuvant chemoradiotherapy on the anal sphincter: ultrastructural damage may be critical.

Authors:  Xiaoming Zhu; Zheng Lou; Haifeng Gong; Ronggui Meng; Liqiang Hao; Wei Zhang
Journal:  Int J Colorectal Dis       Date:  2016-06-08       Impact factor: 2.571

4.  A comparison of the long-term anorectal function between laparoscopic intersphincteric resection and low anterior resection for low rectal cancer.

Authors:  Kenji Kawada; Koya Hida; Suguru Hasegawa; Yoshiharu Sakai
Journal:  Surg Today       Date:  2018-05-11       Impact factor: 2.549

5.  Laparoscopic versus open lateral pelvic lymph node dissection in locally advanced rectal cancer: multicentre retrospective cohort study.

Authors:  Han-Ki Lim; Minjung Kim; Ji Won Park; Seung-Bum Ryoo; Kyu Joo Park; Heung-Kwon Oh; Duck-Woo Kim; Sung-Bum Kang; Dong Woon Lee; Sung Chan Park; Jae Hwan Oh; Seung-Yong Jeong
Journal:  BJS Open       Date:  2022-05-02

6.  Association between pathologic features of peripheral nerves and postoperative anal function after neoadjuvant therapy for low rectal cancer.

Authors:  Keinchi Koushi; Yuji Nishizawa; Motohiro Kojima; Satoshi Fujii; Norio Saito; Ryuichi Hayashi; Atsushi Ochiai; Masaaki Ito
Journal:  Int J Colorectal Dis       Date:  2016-09-21       Impact factor: 2.571

7.  Laparoscopic lateral pelvic lymph node dissection for lower rectal cancer treated with preoperative chemoradiotherapy.

Authors:  Takeru Matsuda; Hiroshi Hasegawa; Kimihiro Yamashita; Tomoko Tanaka; Masashi Yamamoto; Shingo Kanaji; Taro Oshikiri; Tetsu Nakamura; Yasuo Sumi; Satoshi Suzuki; Yoshihiro Kakeji
Journal:  Surg Endosc       Date:  2019-10-18       Impact factor: 4.584

8.  Investigating the association between radiological images and the pathology of rectal cancer treated with neoadjuvant chemotherapy.

Authors:  Satoko Morohashi; Hajime Morohashi; Hiroko Seino; Tadashi Yoshizawa; Toshihiro Haga; Shintaro Goto; Yunyan Wu; Yoshiyuki Sakamoto; Kenichi Hakamada; Hiroshi Kijima
Journal:  Mol Clin Oncol       Date:  2019-10-04

9.  Evaluation of the learning curve for conformal sphincter preservation operation in the treatment of ultralow rectal cancer.

Authors:  Hai-Bo Ding; Lin-Hui Wang; Ge Sun; Guan-Yu Yu; Xian-Hua Gao; Kuo Zheng; Hai-Feng Gong; Jin-Ke Sui; Xiao-Ming Zhu; Wei Zhang
Journal:  World J Surg Oncol       Date:  2022-03-30       Impact factor: 2.754

10.  Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer.

Authors:  Ken Imaizumi; Toshihiro Suzuki; Motohiro Kojima; Manami Shimomura; Naoki Sakuyama; Yuichiro Tsukada; Takeshi Sasaki; Yuji Nishizawa; Akinobu Taketomi; Masaaki Ito; Tetsuya Nakatsura
Journal:  Cancer Sci       Date:  2019-12-18       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.